GSTM1 and diabetes mellitus: In that current diabetes guidelines recommend a goal for hypoglycemic therapy to a glyco Hb of less than 7.5, defining the study group as those who meet a definition for DM but may not yet require hypoglycemic therapy makes the results more applicable for cardiac risk reduction, as opposed to simple glycemic control.